Medivation does not collect or use information from visitors to its website except for the following contacts voluntarily initiated by website visitors:

Medivation will collect name, e-mail address, company name and focus, telephone, fax, and postal address information as voluntarily submitted by website visitors wishing to be informed of news or events related to Medivation, those wishing to be alerted to the start of the Phase 3 Alzheimer's disease trial, or those wishing investor information. Use of that information will be strictly for the purpose of sending these alerts and investor information, and will not be shared with outside parties except as needed to meet that request.

Medivation will collect contact information and content for any e-mail, fax, telephone call, or letter we receive. Use of that information will depend upon the content of the e-mail, fax, telephone call, or letter, but will not be shared with outside parties except as needed to respond to the content of that contact.